Check Cap Ltd is an Israel-based clinical-stage medical diagnostics company. Check Cap Ltd develops C-Scan, patient-friendly preparation-free test designed to detect polyps before they may transform into cancer to enable early intervention and cancer prevention. It's capsule-based screening technology aims to increase screening adherence worldwide. The system utilizes ultra-low-dose X- rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities. C-Scan is non-invasive capsule that is propelled through the gastrointestinal tract by natural motility. C-Scan is comprised of three main components: C-Scan Cap, an ingestible X-ray scanning capsule; C-Scan Track, three miniaturized patches worn on the patient’s back for integrated positioning, control and data recording; and C-Scan View, a proprietary software to process and represent 2D and 3D maps of the inner surface of the colon.
企業コードCHEK
会社名Check Cap Ltd
上場日Feb 19, 2015
最高経営責任者「CEO」Mr. Alex Ovadia
従業員数- -
証券種類Ordinary Share
決算期末Feb 19
本社所在地29 Abba Hushi Ave.
都市
証券取引所NASDAQ Capital Market Consolidated
国Israel
郵便番号3009000
電話番号97248303401
ウェブサイトhttps://check-cap.com/
企業コードCHEK
上場日Feb 19, 2015
最高経営責任者「CEO」Mr. Alex Ovadia
過去5年間の配当金総支払額は
0.00
米ドルである。

データなし